Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors
Alaunos Therapeutics
Alaunos Therapeutics
Tempus AI
National Institutes of Health Clinical Center (CC)
Incyte Corporation
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NextCure, Inc.
pharmaand GmbH
Incyte Corporation
Incyte Corporation
Seagen Inc.
Seagen Inc.
Gilead Sciences
Novartis
Incyte Corporation
Seagen Inc.
University of Iowa
Amgen
Novartis
University Hospitals Cleveland Medical Center
INSYS Therapeutics Inc